SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imagyn Medical Technologies (imti) -- Ignore unavailable to you. Want to Upgrade?


To: Stephen Woods who wrote (224)5/19/1999 11:12:00 AM
From: Stephen Woods  Respond to of 228
 
Imagyn Medical converts to Chapter 11
Tuesday May 18, 9:12 pm Eastern Time

WILMINGTON, Del., May 18 (Reuters) - Imagyn Medical Technologies Inc. (OTC BB:IMTI - news) equipment maker on Tuesday converted an involuntary Chapter 7 bankruptcy into a Chapter 11 filing as it sought protection for five affiliates, court papers showed.

In papers filed in the U.S. Bankruptcy Court in Delaware, Imagyn, through its Microsurge Inc. subsidiary, listed assets of $4 million and liabilities of $153.1 million, much of it in 12.5 percent senior subordinated notes due 2004.

Among the 20 largest unsecured creditors, Microsurge listed the Bank of New York as trustee for $110 million in notes; Credit Suisse First Boston, $84.2 million in notes; and Turnberry Capital Partners, $12.6 million in notes. Fourteen other creditors hold about $70 million in notes.

According to a note in the petition, Microsurge is an ''obligor/guarantor of a public debt issuance of $110 million.''

On May 3 Imagyn was placed in involuntary Chapter 7 by three of its creditors.

Imagyn of Newport Beach, Calif., makes medical/surgical equipment and supplies.



To: Stephen Woods who wrote (224)5/20/1999 9:47:00 AM
From: Angler  Read Replies (1) | Respond to of 228
 
Stephen:

Thanks for the news which continues deja vu as far as that company is concerned. Like they say in Holland from here on up it's all down hill.
This corp. completely lost its focus building a patchwork quilt of small entities paid for by stockholders shares, dilution and immediate liquidation of share prices along the way.
I don't see any changes for the better. What a mess.

Angler